Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04950296
Title field or adapter rule
{'original_value': 'A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:35.815804+00:00
Published At
2022-07-11T00:00:00+00:00
Record Updated At
2022-07-11
Source Retrieved At
2026-10-31T22:18:52.668840+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Irritable Bowel Syndrome With Diarrhea"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2022-07-11", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT04950296"
protocolSection.identificationModule.officialTitle
"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel Syndrome"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Irritable Bowel Syndrome With Diarrhea (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Group I: L. plantarum UALp-05TM,'], 'description': 'One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.', 'name': 'Group I: L. plantarum UALp-05TM,', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Group II: L. plantarum UALp-05TM,'], 'description': 'One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.', 'name': 'Group II: L. plantarum UALp-05TM,', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Microcrystalline Cellulose'], 'description': 'One capsule to be taken orally before lunch with a glass of water. In case the dose is missed, advise participant to take before dinner.', 'name': 'Microcrystalline cellulose', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.